[Long survival periods after therapy for metastatic or reccurrent cancer (author's transl)].
Out of 671 cases of various cancers, first seen for growing metastases and or recurrences (resectable cases being excluded) the 3 years survival rate has been 18 per cent (121 cases). This result was obtained by various combinations of chemotherapy and radiotherapy. It follows that advanced cases should not be abandoned without any attempt at control, and that earlier treatments in cases being at high risk for metastases would probably further increase such results.
D000230:Adenocarcinoma / Q000401:mortality; D001943:Breast Neoplasms / Q000401:mortality; D018288:Carcinoma, Small Cell / Q000401:mortality; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000401:mortality; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000401:mortality* / Q000628:therapy; D010051:Ovarian Neoplasms / Q000401:mortality
Longues survies thérapeutiques dans les cancers métastasés ou récidivés.